BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23822165)

  • 1. CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells.
    Lu CL; Guo J; Gu J; Ge D; Hou YY; Lin ZW; Ding JY
    Dis Esophagus; 2014 Apr; 27(3):294-302. PubMed ID: 23822165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological significance of stem-like CD133(+)CXCR4(+) cells in esophageal squamous cell carcinoma.
    Lu C; Xu F; Gu J; Yuan Y; Zhao G; Yu X; Ge D
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):386-95. PubMed ID: 26092504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis.
    Tezuka Y; Yonezawa S; Maruyama I; Matsushita Y; Shimizu T; Obama H; Sagara M; Shirao K; Kusano C; Natsugoe S
    Cancer Res; 1995 Sep; 55(18):4196-200. PubMed ID: 7664297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and clinical significance of Nrf2 in esophageal squamous cell carcinoma].
    Mao JT; Tangsakar E; Shen H; Wang ZQ; Zhang MX; Chen JX; Zhang G; Wang JS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1231-3. PubMed ID: 22078454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
    Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
    Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
    Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
    Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
    Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
    Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
    Lu CL; Ji Y; Ge D; Guo J; Ding JY
    Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
    Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
    Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
    Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer.
    Drenckhan A; Kurschat N; Dohrmann T; Raabe N; Koenig AM; Reichelt U; Kaifi JT; Izbicki JR; Gros SJ
    J Surg Res; 2013 Jun; 182(2):250-6. PubMed ID: 23117118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of abnormal expression of Aurora-A in human esophageal squamous cell carcinoma with or without lymph node metastasis].
    Shi J; Xue LY; Yin N; Lu J; Fu M; Dong LJ; Shao SJ; Tong T; Zhan QM
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):748-51. PubMed ID: 21163064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
    Shih CH; Ozawa S; Ando N; Ueda M; Kitajima M
    Clin Cancer Res; 2000 Mar; 6(3):1161-8. PubMed ID: 10741747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of her-2 associated with the progression of esophageal cancer patients.
    Wang G; Zhang W; Jiang W; Luan L
    Hepatogastroenterology; 2013; 60(128):1972-8. PubMed ID: 24719937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.